GB:XLVS ETF Price & Analysis
XLVS ETF Chart & Stats
$882.00
--
Market closed
$882.00
--
Day’s Range― - ―
52-Week Range$693.50 - $889.70
Previous Close$882
VolumeN/A
Average Volume (3M)1.31K
AUM555.32M
NAV865.39
Expense Ratio0.14%
Holdings Count60
Beta0.73
Inception DateDec 16, 2009
Next Dividend Ex-DateN/A
Dividend Yield
(―)Shares OutstandingN/A
Standard DeviationN/A
10 Day Avg. Volume3,228
30 Day Avg. Volume1,315
AlphaN/A
ETF Overview
Invesco Health Care S&P US Select Sector UCITS ETF
The Invesco Health Care S&P US Select Sector UCITS ETF, with the ticker DE:SML4, is a compelling investment vehicle specifically designed for investors seeking targeted exposure to the U.S. health care sector. This sector-focused Exchange Traded Fund (ETF) offers a strategic pathway into a broad-based niche that is pivotal to the global economy and consumer well-being. By tracking the performance of the S&P Select Sector Index, the fund provides access to a diversified basket of health care companies, encompassing a wide spectrum of sub-sectors such as pharmaceuticals, biotechnology, medical devices, and health care providers.
This ETF is particularly appealing for those aiming to capitalize on the robust growth and innovation inherent in the health care industry, driven by factors such as an aging population, technological advancements, and increasing health awareness. With its UCITS status, the fund adheres to rigorous European regulatory standards, ensuring transparency and investor protection. The Invesco Health Care S&P US Select Sector UCITS ETF thus represents a sophisticated choice for investors looking to enhance their portfolios with focused health care exposure, while benefiting from the liquidity and efficiency that ETFs offer.
Invesco Health Care S&P US Select Sector UCITS ETF (XLVS) Fund Flow Chart
Invesco Health Care S&P US Select Sector UCITS ETF (XLVS) 1 year Net Flows: $28M
XLVS ETF News
XLVS ETF FAQ
What was GB:XLVS’s price range in the past 12 months?
GB:XLVS lowest ETF price was $693.50 and its highest was $889.70 in the past 12 months.
What is the AUM of GB:XLVS?
As of Oct 16, 2026 The AUM of GB:XLVS is 555.32M.
Is GB:XLVS overvalued?
According to Wall Street analysts GB:XLVS’s price is currently Undervalued.
Does GB:XLVS pay dividends?
GB:XLVS does not currently pay dividends.
How many shares outstanding does GB:XLVS have?
Currently, no data Available
Which hedge fund is a major shareholder of GB:XLVS?
Currently, no hedge funds are holding shares in GB:XLVS
XLVS ETF Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.
Top 10 Holdings
Eli Lilly And Company
15.08%
Johnson & Johnson
10.47%
Abbvie
7.32%
Merck & Company
5.95%
Unitedhealth Group Inc.
5.79%
Amgen Inc
3.79%
Thermo Fisher Scientific
3.75%
Abbott Laboratories
3.18%
Gilead Sciences
2.93%
Pfizer Inc
2.59%
Total60.84%
See All Holdings









